Compare · MDLN vs MHUA
MDLN vs MHUA
Side-by-side comparison of Medline Inc. (MDLN) and Meihua International Medical Technologies Co. Ltd. (MHUA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and MHUA operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $44.40B.
- Over the past year, MDLN is down 12.9% and MHUA is down 81.8% - MDLN leads by 69.0 points.
- MDLN has hit the wire 20 times in the past 4 weeks while MHUA has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for MHUA).
- Company
- Medline Inc.
- Meihua International Medical Technologies Co. Ltd.
- Price
- $35.51+5.07%
- $7.61-45.80%
- Market cap
- $44.40B
- -
- 1M return
- -10.06%
- -65.53%
- 1Y return
- -12.86%
- -81.84%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2022
- News (4w)
- 20
- 0
- Recent ratings
- 25
- 0
Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest MHUA
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
- Meihua International Announces 1-For-100 Reverse Share Split
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.
- SEC Form 424B3 filed by Meihua International Medical Technologies Co. Ltd.